drug
certolizumab pegol
Marketedupdated 3mo agoby UCB SA
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2indications
investigational
Rheumatoid Arthritis
all catalysts(35)
approval · 35
Apr 22, 2008
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Dec 22, 2008
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Dec 31, 2008
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
May 13, 2009
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Nov 18, 2009
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Jul 29, 2010
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Oct 6, 2010
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Dec 21, 2010
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Jul 26, 2011
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Sep 7, 2011
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Sep 14, 2011
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Apr 17, 2012
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Aug 2, 2012
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Aug 29, 2012
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Oct 5, 2012
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Oct 5, 2012
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Nov 15, 2012
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Sep 27, 2013
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Oct 17, 2013
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Oct 19, 2015
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Feb 3, 2016
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Feb 26, 2016
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Apr 28, 2016
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Jan 4, 2017
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Mar 16, 2018
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Mar 20, 2018
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
May 24, 2018
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Jun 14, 2018
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Feb 27, 2019
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Mar 28, 2019
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Sep 6, 2019
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Dec 22, 2022
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Nov 8, 2023
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Sep 13, 2024
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Sep 23, 2025
approval
CIMZIA (CERTOLIZUMAB PEGOL) — FDA approval
certolizumab pegol
→
Trials studying certolizumab pegol
- phase3A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis
- —CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)
- —Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA)
- phase3Pediatric Arthritis Study of Certolizumab Pegol
- phase1A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)
- phase4IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
- phase1A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis
- phase2A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that